EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

miRNA regulation of the Akt/mTOR pathway in oral squamous cell carcinoma: a focused review

Shazia Fathima Jaffer Hussain, Mohammad Fareed, Mohmed Isaqali Karobari

Discover Oncology · 17.07.2025 · 16 (1)

DOI: 10.1007/s12672-025-03073-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Discover Oncology, online erschienen am 17.07.2025. Verfasst von Shazia Fathima Jaffer Hussain und 2 weiteren Autor:innen. Beteiligte Einrichtung: Global Research Cell, Dr. D. Y. Patil Dental College & Hospital, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, 411018, India. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral squamous cell carcinoma (OSCC) contributes significantly to global cancer mortality, characterized by a progression from hyperplasia to invasive cancer through a series of genetic and epigenetic alterations. Central to this progression is the Akt/mTOR signaling pathway, which regulates cell proliferation and survival. This review examines the role of microRNAs (miRNAs) in modulating the Akt/mTOR pathway and their implications for OSCC. The Akt/mTOR pathway, activated by receptor tyrosine kinases and involving the PI3K/AKT/mTOR complexes, is crucial for tumor cell growth and metabolism. Dysregulation of this pathway is frequently observed in OSCC, leading to increased proliferation, survival, and metastasis. miRNAs, such as miR-21, miR-99, and miR-145, play significant roles in regulating this pathway by influencing key components like Akt and mTOR. These miRNAs can act as oncogenes or tumor suppressors, affecting cancer progression and response to therapy. The review highlights the potential of targeting miRNAs for OSCC treatment, including strategies to restore normal miRNA levels or inhibit aberrant miRNAs. Such targeted therapies offer promise for improving treatment outcomes and overcoming drug resistance in OSCC.

Schlagwörter

Stichwörter der Autor:innen

Akt/mTOR signaling pathwayBiomarkersCancer metastasisCell proliferationEpigenetic modificationsGenetic alterationsMicroRNAsOral squamous cell carcinomaTherapeutic targets

Autor:innen und Institutionen

  • Global Research Cell, Dr. D. Y. Patil Dental College & Hospital, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, 411018, India.
  • Department of Basic Medical Sciences, College of Medicine, AlMaarefa University, P.O. Box: 71666, Diriyah, Riyadh, 11597, Saudi Arabia.
  • Department of Conservative Dentistry and Endodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, 600077, India. dr.isaq@gmail.c…
  • Department of Conservative Dentistry and Endodontics, Faculty of Dentistry, University of Puthisastra, Phnom Penh, 12211, Cambodia. dr.isaq@gmail.com.

Zitieren

APA

Hussain, S. F. J., Fareed, M., & Karobari, M. I. (2025). miRNA regulation of the Akt/mTOR pathway in oral squamous cell carcinoma: a focused review. Discover Oncology, 16(1). https://doi.org/10.1007/s12672-025-03073-2

Vancouver

Hussain SFJ, Fareed M, Karobari MI. miRNA regulation of the Akt/mTOR pathway in oral squamous cell carcinoma: a focused review. Discover Oncology. 2025;16(1). doi:10.1007/s12672-025-03073-2

BibTeX
@article{Hussain2025,
  author = {Hussain, Shazia Fathima Jaffer and Fareed, Mohammad and Karobari, Mohmed Isaqali},
  title = {miRNA regulation of the Akt/mTOR pathway in oral squamous cell carcinoma: a focused review},
  journal = {Discover Oncology},
  year = {2025},
  volume = {16},
  number = {1},
  doi = {10.1007/s12672-025-03073-2}
}
Kostenlos starten →